A STUDY OF THE EFFECTIVENESS OF THE IRON-CHELATING AGENT DEFEROXAMINE AS VASOSPASM PROPHYLAXIS IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE

被引:64
|
作者
VOLLMER, DG
HONGO, K
OGAWA, H
TSUKAHARA, T
KASSELL, NF
机构
[1] UNIV VIRGINIA,HLTH SCI CTR,DEPT NEUROSURG,CHARLOTTESVILLE,VA 22903
[2] WASHINGTON UNIV,SCH MED,DEPT NEUROSURG,ST LOUIS,MO 63110
关键词
DEFEROXAMINE; FREE RADICAL; IRON; SUBARACHNOID HEMORRHAGE; VASOSPASM;
D O I
10.1227/00006123-199101000-00005
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The pathogenesis of cerebral vasospasm occurring after subarachnoid hemorrhage (SAH) is unknown. Several lines of experimentation have suggested a free radical mechanism in the etiology of vasospasm. Iron is an important catalyst in the generation of free radicals and lipid peroxides in response to tissue injury. We hypothesize that the elaboration of iron from the subarachnoid clot might result in enhanced generation of free radicals and lipid peroxidation. If so, then treatment with deferoxamine, an iron-chelating compound, might reduce the formation of free radicals and thereby ameliorate vasospasm. This hypothesis was examined in a rabbit model of experimental cerebral vasospasm. New Zealand White rabbits were divided into the following experimental groups: control (normal) animals (n = 7), control animals treated with deferoxamine (n = 3), animals subjected to SAH and killed on Day 2 (n = 7), animals subjected to SAH on Day 2 and treated with deferoxamine (n = 9), animals subjected to SAH killed on Day 3 (n = 7), and animals subjected to SAH on Day 3 and treated with deferoxamine (n = 7). Deferoxamine treatment (50 mg/kg/ 8 hours) was begun 16 hours before the induction of SAH and continued until the animals were killed by perfusion fixation. The basilar artery caliber was assessed using morphometric techniques. The diameter of the basilar arteries in the control animals was 0.64 +/- 0.02 mm. Deferoxamine treatment alone did not alter the artery diameter. SAH resulted in a decrease in basilar artery diameter by 20% on Day 2 and 27% on Day 3. Deferoxamine treatment attenuated the SAH-induced spasm minimally on Day 2 but significantly on Day 3 (Day 3 diameter = 0.60 +/- 0.04; P < 0.015). These preliminary results show promise for deferoxamine therapy in the treatment of vasospasm occurring after SAH. These data support the notion that SAH-induced vasospasm is mediated iron, possibly via the generation of free radicals.
引用
收藏
页码:27 / 32
页数:6
相关论文
共 41 条
  • [1] INHIBITION OF DELAYED ARTERIAL NARROWING BY THE IRON-CHELATING AGENT DEFEROXAMINE
    HARADA, T
    MAYBERG, MR
    JOURNAL OF NEUROSURGERY, 1992, 77 (05) : 763 - 767
  • [2] Comparison of cardiac dysfunction in thalassemia major patients using deferoxamine or deferiprone as an iron-chelating agent
    Josep, Rosalina
    Wahidiyat, Pustika Amalia
    Trihono, Partini Pudjiastuti
    Yanuarso, Piprim B.
    PAEDIATRICA INDONESIANA, 2012, 52 (05) : 272 - 279
  • [3] HISTIDINE ATTENUATES CEREBRAL VASOSPASM IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE
    FADEL, MM
    FOLEY, PL
    KASSELL, NF
    LEE, KS
    SURGICAL NEUROLOGY, 1995, 43 (01): : 52 - 57
  • [4] Synthesis of nano-niosomal deferoxamine and evaluation of its functional characteristics to apply as an iron-chelating agent
    Marzban, Adel
    Akbarzadeh, Azim
    Ardestani, Mehdi Shafiee
    Ardestani, Fatemeh
    Akbari, Mohsen
    CANADIAN JOURNAL OF CHEMICAL ENGINEERING, 2018, 96 (01): : 107 - 112
  • [5] Inhibitory effects of lidocaine on cerebral vasospasm in a rabbit model of subarachnoid hemorrhage
    Shi, Xianqing
    Ye, Baning
    Hu, Yuandong
    Wang, Yuhui
    Li, Jianquan
    Liao, Daqing
    Liu, Jin
    NEURAL REGENERATION RESEARCH, 2010, 5 (21) : 1657 - 1662
  • [6] HISTIDINE ATTENUATES CEREBRAL VASOSPASM IN A RABBIT MODEL OF SUBARACHNOID HEMORRHAGE - COMMENTARY
    FINDLAY, JM
    SURGICAL NEUROLOGY, 1995, 43 (01): : 57 - 58
  • [7] Delayed administration of simvastatin prevents vasospasm in a rabbit model of subarachnoid hemorrhage
    Pradilla, G
    Thai, QA
    Legnani, FG
    Raman, SP
    Hdeib, A
    McGirt, MJ
    Tamargo, RJ
    Clatterbuck, RE
    JOURNAL OF NEUROSURGERY, 2005, 102 (02) : A423 - A424
  • [9] Human tissue kallikrein ameliorates cerebral vasospasm in a rabbit model of subarachnoid hemorrhage
    Mo Yunchang
    Dai Qinxue
    Ji Binbin
    He Xin
    Yang Lili
    Chen Linbi
    Geng Wujun
    Zhang Pengbo
    Wang Junlu
    NEUROLOGICAL RESEARCH, 2015, 37 (12) : 1082 - 1089
  • [10] Establishment of a new symptomatic cerebral vasospasm model following subarachnoid hemorrhage in rabbit
    施国君
    高国栋
    刘俊雄
    王敏
    中国临床康复, 2002, (01) : 134 - 135